Serological Response to COVID-19 Vaccination in Saudi Arabia: A Comparative Study of IgG and Neutralising Antibodies Across Vaccine Platforms.

Vaccines (Basel) · 2025 · PMC12568187 · PMID 41150430

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

approached significancep = 0.056so close (0.05 < p ≤ 0.1)

Pairwise comparisons revealed a statistically significant difference between Moderna and AstraZeneca ( p = 0.012), while the difference between Moderna and Pfizer approached significance but did not reach the threshold ( p = 0.056). 3.4.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.